VulnerabilityAnalyzed
CVE-2025-64642
NMIS/BioDose V22.02 and previous versions' installation directory paths by default have insecure file permissions, which in certain deployment scenarios can enable users on client workstations to modify the program executables and libraries.
HIGH 7.1EPSS 0.12%
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (0.12%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
NMIS/BioDose V22.02 and previous versions' installation directory paths by default have insecure file permissions, which in certain deployment scenarios can enable users on client workstations to modify the program executables and libraries.
- CVSS 4.0
- 7.1 HIGHCVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:L/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/M
- EPSS
- 0.12% probability · 2th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-732
- Affected
- mirion/biodose\/nmis
- Source
- ics-cert@hq.dhs.gov
References
- https://www.cisa.gov/news-events/ics-medical-advisories/icsma-25-336-01Third Party Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.